BackRVL Pharmaceuticals plc Overview

RVL Pharmaceuticals plc Current Assets

Latest current assets for RVLP: $26M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$25.75M
35.92% YoYΔ $-14.44M vs prior year quarter

Peer average

Loading

RVL Pharmaceuticals plc Current Assets History

Loading

RVL Pharmaceuticals plc vs. peers: Current Assets Comparison

Loading

RVL Pharmaceuticals plc Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RVL Pharmaceuticals plc (RVLP) FAQ

As of the most recent data (June 2023), RVLP shows a current assets of $26M. That compares with $40M in the prior-year period — down 35.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RVLP's current assets is now $26M (was $40M) — a 35.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether RVL Pharmaceuticals plc is outperforming or lagging.

Tracking RVLP's current assets over time shows whether RVL Pharmaceuticals plc is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $40M in the prior-year period — down 35.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has RVL Pharmaceuticals plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $26M) with ownership activity and broader fundamentals.

RVL Pharmaceuticals plc's current assets is $26M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.